Understanding how immune cells create diverse antibodies
Chromatin looping directed RAG targeting during V(D)J recombination
This study is looking at how certain parts of our DNA work together to help B cells create a wide variety of antibodies, which are important for fighting off infections, and it could help us understand more about how our immune system works and what might go wrong in some diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan State University NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-10986127 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind the assembly of the immunoglobulin heavy chain locus, which is crucial for generating a diverse antibody repertoire in B cells. It focuses on how chromatin interactions and 3D genome topology influence the targeting of RAG endonucleases during V(D)J recombination, a key process in adaptive immunity. By utilizing advanced techniques to map chromatin interactions, the study aims to uncover the regulatory elements that facilitate this process, potentially leading to new insights into immune function and disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with B-cell deficiencies or related immune disorders.
Not a fit: Patients with non-immune related conditions or those who do not have B-cell deficiencies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of immune system functioning and lead to improved treatments for immune-related diseases.
How similar studies have performed: Previous research has shown promising results in understanding chromatin interactions in immune cells, suggesting that this approach could yield valuable insights.
Where this research is happening
East Lansing, United States
- Michigan State University — East Lansing, United States (Active)
Researchers
- Principal investigator: Zhang, Yu — Michigan State University
- Study coordinator: Zhang, Yu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.